title: Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease. Improvement by the dopamine agonist apomorphine.
authors.affiliation: Laboratoire de Pharmacologie Médicale et Clinique, INSERM U317, Faculté de Médecine, Toulouse, France.
authors.forename: O J
authors.initials: OJ
authors.lastname: Rascol
authors.forename: U
authors.initials: U
authors.lastname: Sabatini
authors.forename: F
authors.initials: F
authors.lastname: Chollet
authors.forename: J L
authors.initials: JL
authors.lastname: Montastruc
authors.forename: J P
authors.initials: JP
authors.lastname: Marc-Vergnes
authors.forename: A
authors.initials: A
authors.lastname: Rascol
mesh_terms: D000368:Aged; D001058:Apomorphine / Q000627:therapeutic use*; D001921:Brain / Q000098:blood supply; D004298:Dopamine / Q000502:physiology; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D009044:Motor Cortex / Q000187:drug effects* / Q000503:physiopathology; D009069:Movement Disorders / Q000188:drug therapy* / Q000503:physiopathology; D009127:Muscle Rigidity / Q000188:drug therapy / Q000503:physiopathology; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D012039:Regional Blood Flow / Q000187:drug effects / Q000502:physiology; D013003:Somatosensory Cortex / Q000187:drug effects / Q000503:physiopathology; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D007980:Levodopa; D001058:Apomorphine; D004298:Dopamine